跳至主要内容
临床试验/EUCTR2017-001878-42-ES
EUCTR2017-001878-42-ES进行中(未招募)1 期

Sildenafil Citrate effect on in vivo human trophoblast research. - Sildenafil Citrate effect on in vivo human trophoblast research.

CONSORCIO HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA0 个研究点目标入组 60 人开始时间: 2017年12月21日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 1. Healthy women between 20-40 years old.
  • 2. Confirmed pregnant viability without any obstetric complication.
  • 3. First trimester gestational age.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 66
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • - Obstetric risk factors : recurrent miscarriage, previous preeclamsia and hematology disease.
  • - Current use of vasoactive drugs. ( mainly related to hypertension treatment).
  • - Toxic substances abuse.
  • - Threatened abortion symptoms.
  • - Sildenafil Citrate contraindications, as are described in the prescribing information formulary (
  • exluding pregnancy).

研究者

相似试验